Last updated 2026-07-20
- Raised $7.5M grant led by OrganaBio, May 2026
- Raised $6.7M Series A led by Excell Partners, Mar 2022
- Raised $10M Seed Extension led by Investment Company (unnamed in source), Apr 2019
Total raised
$24.9M
Last: Undisclosed Round 2026-05
Stage
Series A
Founded
2005
Headcount
14
HQ
Jerusalem, Israel
Sector
Health Tech & Life Sciences
Website ↗Registrar ID: 515903466 (Neurogenesis)
About
NeuroGenesis is a clinical-stage cellular therapy company focused on developing novel and effective treatments for neurodegenerative diseases. The company's proprietary NG CELL™ platform utilizes a unique subpopulation of bone marrow stem cells that are selected and enhanced to become remyelinating and regenerative biofactory cells. This technology aims to slow and halt neurodegeneration in patients with debilitating neurological diseases such as progressive multiple sclerosis (MS) and amyotrophic lateral sclerosis (ALS).
Funding history · 5 rounds · $24.9M total
5 events/rounds · $24.9M Total Funding: $17.4M in Private Equity
May 2026
Grant
$7.5M
ivc-online.com
May 2025
★ National MS Society's Fast Forward programNational MS SocietyIsrael Innovation AuthorityNational Multiple Sclerosis SocietyNational Multiple Sclerosis Society's Fast Forward Program
Mar 2022
A Round
$6.7M
ivc-online.com
★ Excell PartnersHadasitRhodiumMorgan StanleyGovernment FundNew York VenturesInvestment Companyone undisclosed investorNew York State Office of Community Renewal
Apr 2019
★ Investment Company (unnamed in source)Investment CompanyExcell Technology Partners
Jan 2007
Seed
$750K
jpost.com
★ Silicom Ventures FundLightspeed-Gemini Internet LabSilicom Ventures Fund's members
Headcount over time
14 employees (2026-09) · 1 point
Offices
Jerusalem, Israel · HQ / main office
Show all offices (1 more)
- Rochester, United States
Q&A
- What is Neurogenesis's primary focus?
- Neurogenesis is a clinical-stage cellular therapy company focused on utilizing a proprietary subpopulation of bone marrow stem cells to treat central nervous system diseases like progressive multiple sclerosis and amyotrophic lateral sclerosis.
- When was Neurogenesis founded?
- Neurogenesis was founded in September 2018.
- How many employees does Neurogenesis have?
- Neurogenesis has 1-10 employees.
- What is Neurogenesis's total funding to date?
- Neurogenesis has raised a total of $7,660,000.
- When was Neurogenesis's most recent funding round and who participated?
- In May 2026, Neurogenesis received a grant of $1,000,000 from BIRD Foundation.
- Which investors participated in Neurogenesis's March 2022 funding round?
- In March 2022, Rhodium and Excell Partners participated in a private funding round for Neurogenesis.
- Who are the co-founders of Neurogenesis?
- The co-founders of Neurogenesis are Tal Gilat (CEO), Ibrahim Kassis (CTO), and Dimitrios Karussis (CSO).
- Where is Neurogenesis headquartered?
- Neurogenesis is headquartered in Ramat Gan, Israel.
Team · 6
Dimitrios Karussis
Founder · Co-Founder and Chief Scientific Officer
Tal Gilat
Founder · Co-Founder and Chief Executive Officer
Ibrahim Kassis
Founder · Co-Founder and Chief Technology Officer
Nir Netzer
Chief Operating Officer
Mark Freedman
Chief Medical and Head of Scientific Advisory Board
Dorit Harati
Senior VP Quality and Regulatory Affairs
Sectors & technology
Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesPharma & Medical BiotechnologyDrugs Discovery & Development
Technologies
BiologicalsCells
Target customers
Healthcare & Life SciencesLife SciencesHealthcare
Business model
B2B
Tags
pharmaceuticalscell-therapyamyotrophic-lateral-sclerosis-als
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)
External links
| Website | neurogenesis-cell.com/ |
|---|
Identifiers & details
| Founded | 2005 |
|---|---|
| Employees (exact) | 14 |
| Offices | Rochester |
Radar intelligence
Patents
| EPO | 4 |
|---|
Publications (Crossref)
| Works | 10 |
|---|
Web history (Wayback)
| Domain | neurogenesis-cell.com |
|---|
Certificate / subdomain footprint
| Subdomains | 2 |
|---|
Israeli Companies Registrar (רשם החברות / ICA)
| Registrar # (ח.פ.) | 515903466 |
|---|---|
| Status | פעילה |
| Corp type | ישראלית חברה פרטית |
| Incorporated | 2018-09-16 |
| Purpose | לעסוק בכל עיסוק חוקי |
| Liability | מוגבלת |
| In violation (unfiled) | yes |
| Last annual report | 2023 |
| Active charges / liens | 0 |
| Registry events | 1 — violation (1) |
| Registered address | תובל 11 רמת גן |
Recent registry events
| Date | Event |
|---|---|
| 2026-06-25 | עדכון הפרה |